Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
IO Biotech, Inc. - Common Stock
(NQ:
IOBT
)
1.460
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.460
Bid (Size)
1.370 (1)
Ask (Size)
1.490 (1)
Prev. Close
1.460
Today's Range
1.460 - 1.460
52wk Range
0.8163 - 2.640
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 06, 2024
Via
Benzinga
IOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023
March 05, 2024
IOBT stock results show that IO Biotech missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
-23.56%
-23.56%
1 Month
-15.61%
-15.61%
3 Month
-17.51%
-17.51%
6 Month
+52.08%
+52.08%
1 Year
-21.51%
-21.51%
More News
Read More
Top 5 Health Care Stocks That May Crash This Month
January 22, 2024
Via
Benzinga
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 27, 2023
Via
Benzinga
IO Biotech: Q3 Earnings Insights
November 13, 2023
Via
Benzinga
Expert Ratings for IO Biotech
September 28, 2023
Via
Benzinga
IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying
November 27, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 24, 2023
Via
Benzinga
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
June 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 14, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 14, 2023
Via
Benzinga
Why Are IO Biotech Shares Trading Lower Today
June 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 14, 2023
Via
Benzinga
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 14, 2023
Via
Benzinga
Heritage Insurance And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
March 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 28, 2022
Via
Benzinga
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 05, 2022
Via
Benzinga
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
July 25, 2022
Via
Benzinga
Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
July 18, 2022
Via
Benzinga
IO Biotech Starts Dosing In Late-Stage IO102-IO103/Keytruda Combo Trial In Melanoma Patients
May 18, 2022
Via
Benzinga
IO Biotech Reveals Updated Data From IO102-IO103/Opdivo Combo Trial In Melanoma
April 11, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.